Literature DB >> 28595547

Beneficial Effects of N-acetylcysteine and N-mercaptopropionylglycine on Ischemia Reperfusion Injury in the Heart.

Monika Bartekova1, Miroslav Barancik1, Kristina Ferenczyova1, Naranjan S Dhalla2.   

Abstract

BACKGROUND: Ischemia-reperfusion (I/R) injury of the heart as a consequence of myocardial infarction or cardiac surgery represents a serious clinical problem. One of the most prominent mechanisms of I/R injury is the development of oxidative stress in the heart. In this regard, I/R has been shown to enhance the production of reactive oxygen/nitrogen species in the heart which lead to the imbalance between the pro-oxidants and antioxidant capacities of the endogenous radical-scavenging systems.
OBJECTIVES: Increasing the antioxidant capacity of the heart by the administration of exogenous antioxidants is considered beneficial for the heart exposed to I/R. N-acetylcysteine (NAC) and Nmercaptopropionylglycine (MPG) are two sulphur containing amino acid substances, which belong to the broad category of exogenous antioxidants that have been tested for their protective potential in cardiac I/R injury. OBSERVATIONS: Pretreatment of hearts with both NAC and MPG has demonstrated that these agents attenuate the I/R-induced alterations in sarcolemma, sarcoplasmic reticulum, mitochondria and myofibrils in addition to improving cardiac function. While experimental studies have revealed promising data suggesting beneficial effects of NAC and MPG in cardiac I/R injury, the results of clinical trials are not conclusive because both positive and no effects of these substances have been reported on the post-ischemic recovery of heart following cardiac surgery or myocardial infarction.
CONCLUSION: It is concluded that both NAC and MPG exert beneficial effects in preventing the I/Rinduced injury; however, further studies are needed to establish their effectiveness in reversing the I/R-induced abnormalities in the heart. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Ischemia-reperfusion; N-acetylcysteine; N-mercaptopropionylglycine; cardiac function; heart injury; subcellular defects

Mesh:

Substances:

Year:  2018        PMID: 28595547     DOI: 10.2174/0929867324666170608111917

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  12 in total

1.  The Effect of Perioperative N-acetylcysteine on the Short and Long Term Outcomes in Pediatrics Undergoing Living-Donor Liver Transplantation.

Authors:  F Khalili; M B Khosravi; M A Sahmeddini; M H Eghbal; K Kazemi; S Nikeghbalian; S Ghazanfar Tehran; B Khosravi
Journal:  Int J Organ Transplant Med       Date:  2021

Review 2.  The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.

Authors:  Xuexian Fang; Hossein Ardehali; Junxia Min; Fudi Wang
Journal:  Nat Rev Cardiol       Date:  2022-07-04       Impact factor: 49.421

3.  N‑acetyl cysteine prevents ambient fine particulate matter‑potentiated atherosclerosis via inhibition of reactive oxygen species‑induced oxidized low density lipoprotein elevation and decreased circulating endothelial progenitor cell.

Authors:  Yixin Xu; Haoran Bu; Yufan Jiang; Xiaoqing Zhuo; Ke Hu; Zhihua Si; Yong Chen; Qiwei Liu; Xianwei Gong; Haihui Sun; Qingyi Zhu; Lianqun Cui; Xiaochun Ma; Yuqi Cui
Journal:  Mol Med Rep       Date:  2022-05-27       Impact factor: 3.423

4.  ROLE OF THIOLS IN OXIDATIVE STRESS.

Authors:  Shahid P Baba; Aruni Bhatnagar
Journal:  Curr Opin Toxicol       Date:  2018-03-21

Review 5.  Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments.

Authors:  Mi Xiang; Yingdong Lu; Laiyun Xin; Jialiang Gao; Chang Shang; Zhilin Jiang; Hongchen Lin; Xuqin Fang; Yi Qu; Yuling Wang; Zihuan Shen; Mingjing Zhao; Xiangning Cui
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

6.  The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury.

Authors:  Yang Xiao; Karen Yim; Hong Zhang; Diane Bakker; Rianne Nederlof; Jan A M Smeitink; Herma Renkema; Markus W Hollmann; Nina C Weber; Coert J Zuurbier
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-29       Impact factor: 3.727

7.  N-Acetylcysteine Slows Down Cardiac Pathological Remodeling by Inhibiting Cardiac Fibroblast Proliferation and Collagen Synthesis.

Authors:  Jin Zhou; Jing Xu; Shan Sun; Mengyuan Guo; Peng Li; Aijuan Cheng
Journal:  Dis Markers       Date:  2021-11-26       Impact factor: 3.434

8.  An antioxidant system through conjugating superoxide dismutase onto metal-organic framework for cardiac repair.

Authors:  Jiacheng Guo; Zhenzhen Yang; Yongzheng Lu; Chunyan Du; Chang Cao; Bo Wang; Xiaoting Yue; Zenglei Zhang; Yanyan Xu; Zhen Qin; Tingting Huang; Wei Wang; Wei Jiang; Jinying Zhang; Junnan Tang
Journal:  Bioact Mater       Date:  2021-08-22

9.  N-acetylcysteine Ameliorates Vancomycin-induced Nephrotoxicity by Inhibiting Oxidative Stress and Apoptosis in the in vivo and in vitro Models.

Authors:  Ping Yu; Jing Luo; Huahua Song; Tianwei Qian; Xuan He; Jie Fang; Wenpei Dong; Xiaolan Bian
Journal:  Int J Med Sci       Date:  2022-04-11       Impact factor: 3.738

10.  N-acetylcysteine protects hepatocytes from hypoxia-related cell injury.

Authors:  Jan Heil; Daniel Schultze; Peter Schemmer; Helge Bruns
Journal:  Clin Exp Hepatol       Date:  2018-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.